ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993